Director & CHAIRMAN & CEO
Director & CHAIRMAN & CEO at Kiniksa Pharmaceuticals International, plc, filing insider transactions between 2025-05-07 and 2026-05-01.
| SEC ↗ |
| 2026-04-28 | KNSA | Sale | 51.8K | $54.02 | $2.8M | SEC ↗ |
| 2026-04-28 | KNSA | Sale | 74.6K | $50.43 | $3.8M | SEC ↗ |
| 2026-04-28 | KNSA | Sale | 113.7K | $51.47 | $5.9M | SEC ↗ |
| 2026-04-28 | KNSA | Sale | 243.6K | $52.02 | $12.7M | SEC ↗ |
| 2026-04-06 | KNSA | Sale | 7,278 | $50.01 | $364K | SEC ↗ |
| 2025-10-22 | KNSA | Sale | 97.4K | $38.83 | $3.8M | SEC ↗ |
| 2025-10-21 | KNSA | Sale | 39.3K | $38.77 | $1.5M | SEC ↗ |
| 2025-10-20 | KNSA | Sale | 98.9K | $38.81 | $3.8M | SEC ↗ |
| 2025-10-20 | KNSA | Sale | 22.3K | $39.32 | $877K | SEC ↗ |
| 2025-05-28 | KNSA | Sale | 62.1K | $27.33 | $1.7M | SEC ↗ |
| 2025-05-27 | KNSA | Sale | 19.3K | $27.01 | $522K | SEC ↗ |
| 2025-05-23 | KNSA | Sale | 4,837 | $27.00 | $131K | SEC ↗ |
| 2025-05-20 | KNSA | Sale | 2,349 | $27.02 | $63K | SEC ↗ |
| 2025-05-13 | KNSA | Sale | 2,872 | $27.03 | $78K | SEC ↗ |
| 2025-05-09 | KNSA | Sale | 6,029 | $27.05 | $163K | SEC ↗ |
| 2025-05-08 | KNSA | Sale | 101 | $27.00 | $3K | SEC ↗ |
| 2025-05-07 | KNSA | Sale | 1,965 | $27.00 | $53K | SEC ↗ |